Status:
COMPLETED
The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
Uveitis
Vasculitis
Eligibility:
All Genders
18+ years
Brief Summary
This study will examine the proteins of people with uveitis, or inflammation of the eyes. Evaluating the vitreous, the colorless transparent substance that fills the eyeball in back of the lens, is no...
Detailed Description
Newer therapies to treat many ocular disorders including uveitis are being considered and studied. We do not have a clear picture as to what lymphokines/chemokines are present in the vitreous or anter...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Participants must participate in a study that permits the evaluation of specimens.
- EXCLUSION CRITERIA:
- Eligible participants who do not wish to donate their vitreous specimen or anterior chamber fluid, as appropriate, or blood sample or undergo a blood draw for the purposes of this research study.
Exclusion
Key Trial Info
Start Date :
February 14 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
147 Patients enrolled
Trial Details
Trial ID
NCT00331331
Start Date
February 14 2007
End Date
February 1 2019
Last Update
October 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892